文献速递妇科

全球卵巢癌生存比较:组织学分组与诊断分期(CONCORD-2)

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).
PubMed 文献 · Gynecol Oncol · 2016-12-02

CONCORD-2项目纳入60个国家1995-2009年诊断的695932例15-99岁卵巢癌女性,按六种组织学分组估计年龄标化5年净生存率,并对67个登记处233659例2001-2009年诊断者分析分期生存。结果显示I型上皮性肿瘤2005-09年诊断者5年净生存率40-70%,II型为20-45%,性索间质肿瘤高于其他五组,局限期肿瘤生存率远高于晚期(80% vs 30%)。

要点

  • I型上皮性卵巢肿瘤2005-09年诊断者5年净生存率为40-70%。
  • II型上皮性肿瘤5年净生存率较低,为20-45%。
  • 局限期肿瘤5年净生存率80% vs 晚期30%。

核心结论

  • 不同组织学分组之间生存率差异很大,诊断时分期仍是卵巢癌生存的重要因素。
  • 国际卵巢癌生存比较应纳入组织学分组。

研究设计与样本

  • CONCORD项目是基于人群的全球癌症生存趋势研究,纳入60个国家1995-2009年诊断的695932例15-99岁卵巢癌女性。
  • 定义六种组织学分组:I型上皮、II型上皮、生殖细胞、性索间质、其他特定非上皮和非特异形态,按国家估计年龄标化5年净生存率。
  • 另分析67个癌症登记处2001-2009年诊断的233659例有诊断分期信息的女性,按局限期或晚期估计年龄标化5年净生存率。

主要发现

  • 2005-09年诊断的I型上皮性卵巢肿瘤5年净生存率范围为40-70%。
  • II型上皮性肿瘤5年净生存率低得多,为20-45%。
  • 生殖细胞肿瘤生存率高于II型上皮性肿瘤,但国家间差异也很大。
  • 性索间质肿瘤生存率高于其他五组。
  • 局限期肿瘤生存率远高于晚期(80% vs 30%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ovarian cancer comprises several histological groups with widely differing levels of survival. We aimed to explore international variation in survival for each group to help interpret international differences in survival from all ovarian cancers combined. We also examined differences in stage-specific survival. METHODS: The CONCORD programme is the largest population-based study of global trends in cancer survival, including data from 60 countries for 695,932 women (aged 15-99years) diagnosed with ovarian cancer during 1995-2009. We defined six histological groups: type I epithelial, type II epithelial, germ cell, sex cord-stromal, other specific non-epithelial and non-specific morphology, and estimated age-standardised 5-year net survival for each country by histological group. We also analysed data from 67 cancer registries for 233,659 women diagnosed from 2001 to 2009, for whom information on stage at diagnosis was available. We estimated age-standardised 5-year net survival by stage at diagnosis (localised or advanced). RESULTS: Survival from type I epithelial ovarian tumours for women diagnosed during 2005-09 ranged from 40 to 70%. Survival from type II epithelial tumours was much lower (20-45%). Survival from germ cell tumours was higher than that of type II epithelial tumours, but also varied widely between countries. Survival for sex-cord stromal tumours was higher than for the five other groups. Survival from localised tumours was much higher than for advanced disease (80% vs. 30%). CONCLUSIONS: There is wide variation in survival between histological groups, and stage at diagnosis remains an important factor in ovarian cancer survival. International comparisons of ovarian cancer survival should incorporate histology.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Matz M, Coleman MP, Carreira H, et al. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. 2016. PMID: 27919574. doi:10.1016/j.ygyno.2016.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。